SCHEMBL20030379

SCHEMBL20030379

Cc1ccc(/C=C/c2nnc(Cc3ccccc3)o2)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.42
▸ SMN1; SMN2 Q16637 8/20 0.41
▸ RAB9A P51151 7/20 0.41
▸ NPC1 O15118 6/20 0.41
▸ HPGD P15428 4/20 0.41
▸ ALOX12 P18054 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ GPR55 Q9Y2T6 1/20 0.40
▸ PTK2 Q05397 2/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ METAP2 P50579 1/20 0.37
▸ USP2 O75604 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ ERBB2 P04626 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21654646 0.89 PTK2 (0.46) EGFRSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL21654528 0.85 EGFR (0.42) EGFRSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL21654702 0.84 PTK2 (0.41) SMN1; SMN2RAB9ANPC1HPGDTSHR
SCHEMBL21654808 0.78 PTGER1 (0.38) SMN1; SMN2NPC1HPGDALOX12KMT2A
SCHEMBL21654650 0.78 PTK2 (0.44) SMN1; SMN2RAB9ANPC1HPGDKMT2A
SCHEMBL21654539 0.78 PTK2 (0.47) EGFRSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL21654694 0.78 RAB9A (0.46) EGFRSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL21654541 0.77 PTK2 (0.48) EGFRSMN1; SMN2NPC1HPGDTSHR
SCHEMBL21654763 0.76 NPC1 (0.41) EGFRSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL21654698 0.76 TP53 (0.36) SMN1; SMN2RAB9ANPC1HPGDALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018062978-A1 NOVEL HETEROARYL COMPOUND, ENANTIOMER, DIASTEREOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND ANTIVIRAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT 재단법인 한국파스퇴르연구소 2018-04-05 — — WO disclosed
Send feedback